Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accurate Prediction and Validation of Response to Neoadjuvant Chemotherapy in Cervical Cancer

NCT03229187 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

NCT NCT03229187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03229187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accurate Prediction and Validation of Response to Neoadjuvant Chemotherapy in Cervical Cancer
Lead sponsor
Huazhong University of Science and Technology
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2016
Completion date
September 30, 2020
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, uterine cervical cancer, uterine cervical neoplasms